Endoplasmic reticulum stress-driven LncRNA signature predicts cervical cancer prognosis and guides personalized immunotherapy: a multi-omics and functional validation study
Carcinogenesis · 2025
DOI: 10.1093/carcin/bgaf087 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Carcinogenesis, 2025. Verfasst von Jianchuan Hu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Uterine Cervical Neoplasms, Endoplasmic Reticulum Stress, Biomarkers, Tumor. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Endoplasmic reticulum (ER) stress is a key driver of tumor progression and therapeutic resistance. However, the prognostic role of ER stress-related long non-coding RNAs (lncRNAs) in cervical cancer has not been systematically elucidated. In this study, an ER stress-related lncRNA signature was constructed to evaluate patient prognosis and therapeutic responsiveness. Transcriptomic datasets derived from The Cancer Genome Atlas and the Genotype-Tissue Expression project were integrated, leading to the identification of 197 ER stress-associated differentially expressed genes and 1077 co-expressed lncRNAs. A prognostic 8-lncRNA model was developed using univariate/multivariate Cox regression and least absolute shrinkage and selection operator analysis. The model was validated by survival analysis (Kaplan–Meier and receiver operating characteristic curves), immune infiltration profiling (CIBERSORT and single-sample gene set enrichment analysis), and drug sensitivity analysis. Patients classified into the high-risk category showed significantly shorter overall survival (OS) (log-rank P < .001) and higher chemosensitivity to PI3K/mTOR inhibitors, whereas the low-risk group showed high immune activity (CD8+ T-cell infiltration and checkpoint expression) along with improved responsiveness to Wnt pathway inhibitors. The predictive capacity of the model (area under the curve, AUC: 0.806–0.856) exceeded that of conventional clinical parameters. Functional validation further revealed that LIPE-AS1, a representative high-risk lncRNA, promotes cervical cancer cell proliferation, migration, and invasion. These results introduce a novel ER stress-associated lncRNA signature with prognostic and therapeutic value, thus providing a potential basis for personalized immunotherapeutic and chemotherapeutic strategies in cervical cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
ORCID-Profile: Jianchuan Hu, Zhongbing Qi, Shichuan Hu, Xianglin Xu, Yu Qin, Yao Zhang, Qingzhe Yang, Ping Cheng
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Hu, J., Qi, Z., Hu, S., Xu, X., Qin, Y., Zhang, Y., Yang, Q., & Cheng, P. (2025). Endoplasmic reticulum stress-driven LncRNA signature predicts cervical cancer prognosis and guides personalized immunotherapy: a multi-omics and functional validation study. Carcinogenesis. https://doi.org/10.1093/carcin/bgaf087
Vancouver
Hu J, Qi Z, Hu S, Xu X, Qin Y, Zhang Y, et al. Endoplasmic reticulum stress-driven LncRNA signature predicts cervical cancer prognosis and guides personalized immunotherapy: a multi-omics and functional validation study. Carcinogenesis. 2025. doi:10.1093/carcin/bgaf087
BibTeX
@article{Hu2025,
author = {Hu, Jianchuan and Qi, Zhongbing and Hu, Shichuan and Xu, Xianglin and Qin, Yu and Zhang, Yao and Yang, Qingzhe and Cheng, Ping},
title = {Endoplasmic reticulum stress-driven LncRNA signature predicts cervical cancer prognosis and guides personalized immunotherapy: a multi-omics and functional validation study},
journal = {Carcinogenesis},
year = {2025},
doi = {10.1093/carcin/bgaf087}
}
EUVIMED